Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2022-01-04 2022-01-04
Drug Identification Number 02357380 02357380
Brand name ULORIC ULORIC
Common or Proper name ULORIC 80 mg Tablets ULORIC 80 mg Tablets
Company Name TAKEDA CANADA INC TAKEDA CANADA INC
Ingredients FEBUXOSTAT FEBUXOSTAT
Strength(s) 80MG 80MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size Bottle of 30's Bottle of 30's
ATC code M04AA M04AA
ATC description ANTIGOUT PREPARATIONS ANTIGOUT PREPARATIONS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2021-12-31 2021-12-31
Actual discontinuation date 2021-12-31 2021-12-31
Remaining supply date 2021-12-31 2021-12-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments